IL1R1 and acute myeloid leukemia: Stratmann et al. [40] reported IL1R1 as a biomarker associated with AML progression and attenuated cellular growth and disease progression in primary AML cells, and AML murine models can be observed when suppressing IL-1 signaling [41].